Granted Patent
B2
US 8,168,191 · App. 12/113,822 · Granted May 1, 2012
Cytotoxic T lymphocyte
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention relates to a T lymphocyte having an activity to induce a T lymphocyte recognizing an antigen and a technique to use the T lymphocyte.
Claims (2)
1. An inducer of a cytotoxic T lymphocyte containing an isolated human major histo-compatibility antigen (HLA)-A24-restricted antigen peptide consisting of SEQ ID NO: 2 as an active ingredient.
2. A tetramer for detecting a T cell receptor possessed by a cytotoxic T lymphocyte, comprising an isolated human major histo-compatibility antigen (HLA)-A24-restricted antigen peptide consisting of SEQ ID NO: 2.
Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Aug 29, 2019
From: TAKARA BIO INC.
To: MIE UNIVERSITY
Reel/Frame 050213/0980 →
CHANGE OF ADDRESS
Recorded Jun 24, 2016
From: TAKARA BIO INC.
To: TAKARA BIO INC.
Reel/Frame 039152/0834 →
Priority Claims (1)
JP 2004-290785
· Oct 1, 2004
· national
Continuity (2)